Kantonsspital Baselland

METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII (2024) Kocak B, Akinci D’Antonoli T, Mercaldo N, Alberich-Bayarri A, Baessler B, Ambrosini I, Andreychenko AE, et al. Journal article Lymph node metastases and recurrence in pT1 colorectal cancer: Prediction with the International Budding Consortium Score—A retrospective, multi-centric study (2024) Dawson H, Bokhorst JM, Studer L, Vieth M, Oguz Erdogan AS, Kus Öztürk S, Kirsch R, et al. Journal article, Original article Immunomodulation with romiplostim as a second-line strategy in primary immune thrombocytopenia: The iROM study (2023) Schifferli A, Rüfer A, Rovo A, Nimmerjahn F, Cantoni N, Holbro A, Favre G, et al. Journal article Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer: Final Report of the OCUM Study (2023) Ruppert R, Junginger T, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, et al. Journal article Machine learning in knee arthroplasty: specific data are key—a systematic review (2022) Hinterwimmer F, Lazic I, Suren C, Hirschmann MT, Pohlig F, Rueckert D, Burgkart R, Von Eisenhart-Rothe R Journal article, Review article Selection of patients with rectal cancer for neoadjuvant therapy using pre-therapeutic MRI-Results from OCUM trial (2022) Stelzner S, Ruppert R, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, et al. Journal article Prediction of complications and surgery duration in primary TKA with high accuracy using machine learning with arthroplasty-specific data (2022) Hinterwimmer F, Lazic I, Langer S, Suren C, Charitou F, Hirschmann MT, Matziolis G, et al. Journal article Pancreatic cancer (2021) Galli R, Schmutz-Kober K, Kuhnel J, Maak M, Rosenberg R Journal article Immunomodulation with Romiplostim in Young Adult Primary Immune Thrombocytopenia (ITP) As Second-Line Strategy (iROM-study) (2021) Schifferli A, Ruefer A, Rovo A, Cantoni N, Holbro A, Favre G, Faeth H, et al. Conference contribution Avoidance of Overtreatment of Rectal Cancer by Selective Chemoradiotherapy: Results of the Optimized Surgery and MRI-Based Multimodal Therapy Trial (2020) Ruppert R, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, Sauer J, et al. Journal article